← All trials
NCT06214858
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 14, 2023
- Primary completion
- Apr 2, 2024
- Completion date
- Apr 30, 2024
- First posted
- Jan 22, 2024
- Last posted
- Jan 22, 2024
- Enrollment
- 76
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ParisOfficial
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.